Home
NewsNewsIran Health Agency Expands Fertility Treatment Services to meet rising global demand, offering advanced testing, IVF, expert consultation, and full post-treatment follow-up. The program also includes visa assistance, travel coordination, accommodation support, and multilingual guidance, ensuring international patients receive structured, end-to-end reproductive care in Iran.
A leading medical tourism facilitator in Iran, Iran Health Agency Expands Fertility Treatment options for international patients in an announcement. These services would have in them advanced evaluation, specialized consultation, and IVF treatments, along with comprehensive post-treatment follow-up.
It is worth noting that the agency coordinates care by way of assisting patients all across the treatment process, right from those initial inquiries and appointment scheduling to post-treatment communication along with the medical providers.
Due to a growing global demand when it comes to high-quality and dependable fertility care, the Iran Health Agency now provides fertility treatment options like a comprehensive range of fertility services, which includes consultation with experts, advanced testing for couples, IVF as well as other assisted reproductive technologies, and of course complete support all throughout the medical journey. These services are crafted to ensure a safe, comfortable, as well as a successful experience as far as international patients traveling to Iran are concerned, especially in the gamut of fertility treatment.
As per the spokesperson from the agency, their mission is to ensure that every step of the fertility treatment journey for international patients is clear, safe, and without any hassles. Through offering complete support right from initial consultation to post-treatment follow-up, patients are going to get the best possible opportunity to attain their family planning targets.
Iran Health Agency now offers a range of services that include the likes of -
Besides the Iran Health Agency Expands Fertility Treatment and offering medical services, the agency also rolls out assistance for visas, travel coordination, accommodation, and airport transfers, as well as 24/7 multilingual support to make sure that the patients complete their treatment journey in a very efficient way, with immense peace of mind.
A groundbreaking Nature Medicine study compares AI deep learning against expert embryologists in selecting embryos. While pregnancy rates remain comparable, the study uncovers a massive advantage in efficiency that could revolutionize IVF labs worldwide. Discover how AI-driven embryo selection accuracy is reshaping the future of fertility treatment.
FertilAI has received EU MDR clearance for tools advancing Predictive AI in Fertility through its Fertilane platform. StimAI and OvuPredict help clinicians optimise IVF timing, predict ovulation and improve scheduling efficiency. The technology supports scalable fertility care, reduced monitoring needs and better patient treatment experiences globally.
The Ferring Global Fertility Monitor has been launched by Ferring Pharmaceuticals and Gallup to examine fertility trends in 70 countries. Through large-scale surveys, the project will explore economic, social, and cultural influences on parenthood decisions. Insights are expected to guide policy, healthcare planning, and future demographic strategies.
Maven Clinic has expanded its Fertility and Family Building program with earlier diagnostics, wearable integration, and AI-powered personalised care. The enhanced platform supports faster diagnosis, improved treatment decisions, and condition-specific pathways for PCOS, endometriosis, and oncofertility. The rollout continues through 2026 with added innovations and partnerships.
Germany is debating the legalization of egg donation in Germany, challenging decades-old restrictions under the Embryo Protection Act. Experts argue reform is overdue to align with modern reproductive science, reduce fertility tourism, and improve patient care, while policymakers work to balance ethical concerns with growing demand for advanced fertility treatments.
A new review highlights the link from Forever Chemicals to reduced ART outcomes, showing how PFAS exposure impacts fertility, pregnancy, and reproductive health. The findings raise urgent concerns for IVF patients and call for stronger regulation, deeper research, and systemic action to address environmental risks in reproductive medicine.
The 2027 Title X NOFO introduces a major policy shift toward addressing infertility crisis in the U.S. It mandates basic infertility services, expands male reproductive health focus, and promotes education on body literacy and lifestyle factors, aiming to support family formation alongside traditional contraceptive services.
